Inflammatory and vascular biomarkers as predictors of all‐cause death and cardiovascular outcomes in an Australian community‐based cohort
Physiological Reports · 2025
DOI: 10.14814/phy2.70379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2025. Verfasst von Silvia Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Harry Perkins Institute of Medical Research, University of Western Australia, Murdoch, Western Australia, Australia. Hauptthemen laut MEDLINE: Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Perth Hospital Medical Research Foundation (RPH-MRF), Wellcome Trust, National Heart Foundation of Australia.
Abstract (Originalsprache)
Biomarkers that identify individuals who are at higher risk of cardiovascular outcomes will allow for early intervention, lowering the incidence of adverse outcomes. This study investigated whether circulating levels of GDF‐15, E‐selectin, CD14, and ST2 are predictors of death and cardiovascular outcomes in 981 individuals who did not have a history of cardiovascular disease (CVD) during follow‐up periods of 5, 10, and 20 years. During the 20‐year follow‐up, there were 389 deaths (including 147 from CVD), 105 participants had acute coronary syndrome (ACS), and 467 people had major adverse coronary and cerebrovascular events (MACCE) (including all‐cause death). In the fully adjusted model, sE‐selectin (5‐year HR, 3.03; 95% CI 1.31–7.01), sCD14 (5 years 3.11; 1.02–9.45 and 10 years 2.52; 1.23–5.16), and sGDF‐15 (10 years 2.07; 1.13–3.78 and 20 years 1.79; 1.24–2.56) predicted all‐cause death. sE‐selectin (5 years 2.19; 1.13–4.26), sCD14 (10 years 2.00; 1.08–3.68), and sGDF‐15 (10 years 1.95; 1.18–3.22 and 20 years 1.53; 1.11–2.12) predicted MACCE. sGDF‐15 predicted ACS at 5 (4.44; 1.01–19.49), 10 (2.86; 1.08–7.57) and 20 years (2.57; 1.31–5.04). High serum levels of sE‐selectin, sGDF‐15, and sCD14 at baseline are important independent risk factors for all‐cause death and cardiovascular outcomes in a population without prevalent CVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Harry Perkins Institute of Medical Research, University of Western Australia, Murdoch, Western Australia, Australia.
- Department of Microbiology, Pathwest Laboratory Medicine, Perth, Western Australia, Australia.
- Department of Clinical Immunology, Pathwest Laboratory Medicine, Perth, Western Australia, Australia.
- School of Population and Global Health, University of Western Australia, Perth, Western Australia, Australia.
- Department of Clinical Immunology, Royal Perth Hospital, Perth, Western Australia, Australia.
- Department of Cardiology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
ORCID-Profile: Silvia Lee, Frank Sanfilippo, Girish Dwivedi
Förderung
- Royal Perth Hospital Medical Research Foundation (RPH-MRF)
- Wellcome Trust
- National Heart Foundation of Australia
Zitieren
APA
Lee, S., Castley, A., Knuiman, M., Nolan, D., Sanfilippo, F., & Dwivedi, G. (2025). Inflammatory and vascular biomarkers as predictors of all‐cause death and cardiovascular outcomes in an Australian community‐based cohort. Physiological Reports. https://doi.org/10.14814/phy2.70379
Vancouver
Lee S, Castley A, Knuiman M, Nolan D, Sanfilippo F, Dwivedi G. Inflammatory and vascular biomarkers as predictors of all‐cause death and cardiovascular outcomes in an Australian community‐based cohort. Physiological Reports. 2025. doi:10.14814/phy2.70379
BibTeX
@article{Lee2025,
author = {Lee, Silvia and Castley, Alison and Knuiman, Matthew and Nolan, David and Sanfilippo, Frank and Dwivedi, Girish},
title = {Inflammatory and vascular biomarkers as predictors of all‐cause death and cardiovascular outcomes in an Australian community‐based cohort},
journal = {Physiological Reports},
year = {2025},
doi = {10.14814/phy2.70379}
}
EUVIMED